REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Mancza Es Fia Patika B.T. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. Mancza Es Fia Patika Gyogyszerkereskedelmi Es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr. Mancza Es Fia Patika B.T. is based in Hungary, with the head office in Sajokaza. It operates in the Pharmacies and Drug Stores sector. The company was established on November 23, 1996. Dr. Mancza Es Fia Patika B.T. currently employs 3 (2024) people. From the latest financial highlights, Dr. Mancza Es Fia Patika B.T. reported a net sales revenue increase of 14.3% in 2023. During that time, Dr. Mancza Es Fia Patika B.T.’s total assets grew by 17.98%. In 2023, Dr. Mancza Es Fia Patika B.T.’s net profit margin increased by 0.88%.

Headquarters
Kossuth u. 8. szam
Sajokaza; Borsod-Abauj-Zemplen; Postal Code: 3720

Contact Details: Purchase the Dr. Mancza Es Fia Patika B.T. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Mancza Es Fia Patika B.T. report to view the information.
Outstanding Shares:
Purchase the Dr. Mancza Es Fia Patika B.T. report to view the information.
Registered Capital:
Purchase the Dr. Mancza Es Fia Patika B.T. report to view the information.
Incorporation Date:
November 23, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Dr. Mancza Es Fia Patika B.T. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.3%
Total operating revenue
11.78%
Operating profit (EBIT)
39.09%
EBITDA
42.6%
Net Profit (Loss) for the Period
85.75%
Total assets
17.98%
Total equity
2.99%
Operating Profit Margin (ROS)
0.62%
Net Profit Margin
0.88%
Return on Equity (ROE)
6.6%
Quick Ratio
-0.24%
Cash Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?